Doctor Becomes First in Illinois to Perform Revolutionary, Minimally Invasive Bladder Control Procedure

DOWN­ERS GROVE, Ill. - Dr. Sarah Mar­tin, a wom­en's urol­o­gy spe­cial­ist at Duly Health and Care's Chicagoland med­ical group, DuPage Med­ical Group, Ltd., this month became the first physi­cian in Illi­nois to per­form a cut­ting-edge, min­i­mal­ly inva­sive blad­der con­trol pro­ce­dure using the Alta­vi­va™ implant.

Mil­lions of women, includ­ing many in the Chicagoland area, now have access to a break­through treat­ment that has the poten­tial to dra­mat­i­cal­ly improve their qual­i­ty of life. The pro­ce­dure takes less than 15 min­utes and deliv­ers imme­di­ate results that can last up to 15 years.

"I'm thrilled to be the first physi­cian in Illi­nois to bring this inno­v­a­tive option to my patients," Dr. Mar­tin said. ​"The implant address­es blad­der con­trol symp­toms in a whole new way, help­ing patients regain com­fort and con­fi­dence with a sin­gle visit."

More than 13% of women expe­ri­ence Urge Uri­nary Incon­ti­nence, or UUI, a con­di­tion marked by the intense urge to uri­nate fol­lowed by invol­un­tary loss of blad­der con­trol. Stud­ies show that blad­der-con­trol prob­lems can sig­nif­i­cant­ly dis­rupt wom­en's lives by reduc­ing their self-con­fi­dence, restrict­ing their abil­i­ty to social­ize, and dis­rupt­ing sleep and intimacy.

The Alta­vi­va™ device is implant­ed just above the ankle through a small, two-cen­time­ter inci­sion, with no seda­tion or imag­ing required. The implant reduces blad­der urgency and incon­ti­nence by stim­u­lat­ing the tib­ial nerve. Clin­i­cal data show that 80% of patients report improved symp­toms, 70% expe­ri­ence mean­ing­ful improve­ments to their qual­i­ty of life, and 61% see their leak­age episodes fall by 50% or more with­in the first year.

Until now, patients with UUI had lim­it­ed and often incon­ve­nient options. Botox injec­tions must be repeat­ed reg­u­lar­ly and car­ry a risk of uri­nary reten­tion and infec­tion. That has led more than two-thirds of patients to stop after the first treat­ment. Sacral neu­ro­mod­u­la­tion has been effec­tive but requires more inva­sive surgery and demands fre­quent in-office vis­its. Addi­tion­al­ly, med­ica­tions that treat UUI can cause cog­ni­tive side effects and can be cost-prohibitive.

Alta­vi­va™ changes all that, com­bin­ing the con­ve­nience of a one-time pro­ce­dure with the proven suc­cess of tib­ial nerve stimulation.

For more infor­ma­tion, sources, and impor­tant safe­ty infor­ma­tion, vis­it www​.Medtron​ic​.com/​A​l​t​aviva

Dr. Mar­tin will per­form the Alta­vi­va™ pro­ce­dure at Duly Surgery Cen­ter Lom­bard, locat­ed at 2725 S. Tech­nol­o­gy Dri­ve in Lom­bard, Ill. To learn more or sched­ule an appoint­ment, vis­it https://​www​.duly​healthand​care​.com/​p​r​o​c​e​d​u​r​e​s​/​a​l​t​a​v​i​v​a​-​t​h​erapy.

###

About Duly Health and Care

The Duly Health and Care brand con­sists of some of the largest inde­pen­dent, mul­ti-spe­­­cial­­­ty, physi­­­cian-direc­t­ed med­ical groups in the nation, with more than 1,000 pri­ma­ry care and spe­cial­ty care providers and over 6,000 team mem­bers across more than 150 loca­tions. The Duly Health and Care brand includes three med­ical groups - DuPage Med­ical Group Ltd., Quin­cy Med­ical Group, and The South Bend Clin­ic LLC. Duly is deeply com­mit­ted to car­ing for patients in tra­di­tion­al and val­ue-based care arrange­ments, ensur­ing a focus on qual­i­ty, effi­cien­cy, and enhanced patient expe­ri­ences through­out the Midwest.

For more infor­ma­tion, vis­it duly​healt­hand​care​.com.